Entecavir versus other oral antiviral drugs for chronic hepatitis B-Reference-Cited by-同舟云学术

Entecavir versus other oral antiviral drugs for chronic hepatitis B

Published:2018-07-26 Issue: Volume: Page:
ISSN:1465-1858
Container-title:Cochrane Database of Systematic Reviews
language:en
Short-container-title:

Author:

Ismail Mona H¹²,Ricaforte-Campos Jane D³,Wiysonge Charles S⁴,Gish Robert⁵⁶⁷⁸⁹

Affiliation:

1. King Fahad Hospital of the University; Divison of Gastroenterology, Department of Internal Medicine; PO BOX 40149 Al Khobar Saudi Arabia 31952

2. College of Medicine, Imam Abdulrahman Bin Faisal University; Dammam Saudi Arabia

3. ManilaMed (Medical Center Manila); Section of Gastroenterogy, Department of Internal Medicine Manila; General Luna 1122 Ermita Manila Philippines 1000

4. South African Medical Research Council; Cochrane South Africa; Francie van Zijl Drive, Parow Valley Cape Town Western Cape South Africa 7505

5. Hepatitis B Foundation; 6022 La Jolla Mesa Drive La Jolla CA USA 92037

6. University of Nevada, Las Vegas; Las Vegas NV USA

7. Asian Pacific Health Foundation; San Diego CA USA

8. University of Nevada; Reno School of Medicine; Reno NV USA

9. Robert G Gish Consultants LLC; La Jolla CA USA

Publisher

Wiley

Subject

Pharmacology (medical)

Link

https://www.cochranelibrary.com/cdsr/doi/10.1002/14651858.CD013081/epdf/full

Reference52 articles.

1. Interaction revisited: the difference between two estimates;Altman;BMJ (Clinical Research Ed.),2003

2. Asian-Pacific consensus statement on the management of chronic Hepatitis B: a 2012 update;Liaw;Hepatology International,2012

3. Epidemiology of hepatocellular carcinoma;Bosch;Clinics in Liver Disease,2005

4. Bristol-Myers Squibb Baraclude package insert packageinserts.bms.com/pi/pi_orencia.pdf

5. Trial Sequential analysis reveals insufficient information size and potentially false positive results in many meta-analyses;Brock;Journal of Clinical Epidemiology,2008